Suspected hereditary hemochromatosis referral based on iron studies
Referral to hematology is indicated when transferrin saturation (TSAT) is elevated above 45% with a ferritin level substantially above the threshold used to suspect iron overload from HFE-related hereditary hemochromatosis. [1][2][3]
Evidence-based biochemical thresholds
Hereditary hemochromatosis (HFE-related) should be suspected with the following biochemical pattern in adults of European ancestry. [1][2]
- TSAT >45% with ferritin >200 µg/L in females. [1]
- TSAT >50% with ferritin >300 µg/L in males and postmenopausal women. [1]
With TSAT above 45% and ferritin approximately 590 ng/mL, the ferritin criterion is exceeded by multiple guideline thresholds used to support evaluation for iron overload. [1][2]
Recommended specialist evaluation after meeting biochemical criteria
HFE genotyping is recommended when biochemical evidence of iron overload is present using guideline TSAT and ferritin cutoffs. [1][2] Referral to a specialist service for HFE genetic testing and staging of iron-related organ involvement is therefore appropriate when the biochemical pattern meets the above criteria. [1][2]
Monotherapy vs combination care: laboratory confirmation prior to definitive diagnosis
A high TSAT with elevated ferritin should be treated as suspected iron overload rather than confirmed hereditary hemochromatosis until secondary causes are excluded and HFE genotyping is completed. [1][2] Inflammatory and hepatic causes of hyperferritinemia should be evaluated alongside repeat iron studies during the diagnostic workup. [2][4]
Initiation thresholds for escalation of care
Specialist referral is warranted when the biochemical thresholds for suspected HFE-related hereditary hemochromatosis are exceeded, because genotyping is recommended at that point. [1][2] Higher-intensity referral for liver fibrosis assessment is generally reserved for patients with markedly advanced biochemical/liver risk features (for example very high ferritin and/or abnormal transaminases in some guidance), and a specific “hematology vs hepatology” distinction varies by health system. [4]
Common pitfalls to avoid in practice
Ferritin elevation has multiple causes and does not confirm hereditary hemochromatosis by itself. [4] Inflammation-related ferritin elevation can produce diagnostic confusion with iron indices, so inflammatory markers and evaluation for other etiologies should be included in the workup. [4]
Treatment goals that depend on confirmed diagnosis (context for referral)
Definitive treatment decisions (such as phlebotomy) are based on confirmation and phenotyping of hereditary hemochromatosis and assessment of iron burden and organ involvement. [1][3]
Conclusion
A patient with TSAT >45% and ferritin ~590 ng/mL meets guideline biochemical criteria that support suspected iron overload from HFE-related hereditary hemochromatosis. [1][2] Referral to hematology (or an equivalent specialist pathway for genetic testing and iron-overload staging) is appropriate to complete HFE genotyping and clinical risk assessment. [1][2]
Sources
[1] EASL Clinical Practice Guidelines on haemochromatosis (2022). [2] Diagnosis and management of hemochromromatosis: 2011 Practice Guideline by AASLD. [3] Management of Hemochromatosis (AASLD practice guideline landing page, updated July 2011). [4] British Society for Haematology guideline: Investigation and management of a raised serum ferritin.